JP6169693B2 - 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤 - Google Patents

次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤 Download PDF

Info

Publication number
JP6169693B2
JP6169693B2 JP2015523491A JP2015523491A JP6169693B2 JP 6169693 B2 JP6169693 B2 JP 6169693B2 JP 2015523491 A JP2015523491 A JP 2015523491A JP 2015523491 A JP2015523491 A JP 2015523491A JP 6169693 B2 JP6169693 B2 JP 6169693B2
Authority
JP
Japan
Prior art keywords
treatment
use according
ulcer
component
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015523491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522632A5 (enExample
JP2015522632A (ja
Inventor
ウルリカ・アルムホエイェデ
カリン・ベリークヴィスト
Original Assignee
アルエルエス グローバル アーベー
アルエルエス グローバル アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルエルエス グローバル アーベー, アルエルエス グローバル アーベー filed Critical アルエルエス グローバル アーベー
Publication of JP2015522632A publication Critical patent/JP2015522632A/ja
Publication of JP2015522632A5 publication Critical patent/JP2015522632A5/ja
Application granted granted Critical
Publication of JP6169693B2 publication Critical patent/JP6169693B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2015523491A 2012-07-24 2013-07-15 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤 Expired - Fee Related JP6169693B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1250891A SE536581C2 (sv) 2012-07-24 2012-07-24 Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
SE1250891-7 2012-07-24
PCT/EP2013/064919 WO2014016157A1 (en) 2012-07-24 2013-07-15 Preparation for treatment of wounds and sores comprising hypochlorite and amino acids

Publications (3)

Publication Number Publication Date
JP2015522632A JP2015522632A (ja) 2015-08-06
JP2015522632A5 JP2015522632A5 (enExample) 2016-06-02
JP6169693B2 true JP6169693B2 (ja) 2017-07-26

Family

ID=48783266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015523491A Expired - Fee Related JP6169693B2 (ja) 2012-07-24 2013-07-15 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤

Country Status (9)

Country Link
US (1) US9999605B2 (enExample)
EP (2) EP3299022A1 (enExample)
JP (1) JP6169693B2 (enExample)
CN (1) CN104619330B (enExample)
CA (1) CA2879362C (enExample)
ES (1) ES2657598T3 (enExample)
MX (1) MX360207B (enExample)
SE (1) SE536581C2 (enExample)
WO (1) WO2014016157A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
AU2014343506C1 (en) 2013-10-29 2023-06-01 Hypo-Stream Limited Anti-inflammatory solution comprising sodium hypochlorite
GB2519774A (en) * 2013-10-29 2015-05-06 Hypo Stream Ltd Anti-inflammatory solution
EP3703805A4 (en) * 2017-10-31 2021-07-28 Otomagnetics, Inc. MAGNETICALLY ASSISTED ADMINISTRATION IN AND THROUGH THE SKIN
RU2684415C1 (ru) * 2018-04-18 2019-04-09 Федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства здравоохранения Российской Федерации, ФГБОУ ВО КубГМУ МЗ РФ Способ лечения гнойных ран
JP2022548928A (ja) * 2019-09-19 2022-11-22 アールエルエス グローバル アーベー Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｅｐｉｄｅｒｍｉｄｉｓに関連する感染症の除去および／または予防のための調製物
RU2741954C1 (ru) * 2020-07-20 2021-02-01 Государственное бюджетное учреждение здравоохранения "Научно-исследовательский институт - краевая клиническая больница N 1 имени профессора С.В. Очаповского" Министерства здравоохранения Краснодарского края (ГБУЗ "НИИ-ККБ N 1 им. проф. Очаповского" Минздрава Краснодарского края) Способ лечения локальных ран головы с остеонекрозом костей свода черепа

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1418193A (en) 1973-03-14 1975-12-17 Wilkinson Sword Ltd Dispenser for hypochlorite gels
US3950536A (en) 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
JPH0233013B2 (ja) 1980-03-21 1990-07-25 Masatoshi Fumiiri Sokonchiryozai
GB8324487D0 (en) 1983-09-13 1983-10-12 Geistlich Soehne Ag Topically administrable pharmaceutical compositions
SE507437C2 (sv) 1996-11-14 1998-06-08 Medi Team Dentalutveckling I G Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet
JPH10175857A (ja) * 1996-12-19 1998-06-30 Sekisui Chem Co Ltd 創傷治療剤
DK1059934T3 (da) 1998-02-27 2002-11-11 Biora Bioex Ab Matrixproteinpræparater til sårheling
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US6350438B1 (en) 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
FR2819723B1 (fr) 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
US20030194445A1 (en) * 2001-11-12 2003-10-16 Kuhner Carla H. Compositions and methods of use of peptides in combination with biocides and/or germicides
AU2003279165A1 (en) 2002-10-07 2004-05-04 Alcide Corporation Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
PL1656095T3 (pl) 2003-08-18 2014-04-30 Novabay Pharmaceuticals Inc N,n-dwuchlorowcowane kwasy aminowe i pochodne
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
US20070032754A1 (en) * 2005-08-02 2007-02-08 Walsh Richard F Method and apparatus for treating a wound
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
KR20080082742A (ko) 2007-03-09 2008-09-12 이향락 충치 제거제
UY31058A1 (es) 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
US7879798B1 (en) 2007-08-24 2011-02-01 Regenicel, Inc. Composition for indolent wound healing and methods of use therefor
UY31055A1 (es) 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
WO2010017405A1 (en) 2008-08-06 2010-02-11 Adam Heller Methods and compositions for the treatment of pain
WO2010091280A1 (en) 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
JP5587969B2 (ja) 2009-03-18 2014-09-10 オラテック インダストリーズ リミティド ライアビリティ カンパニー 炎症及び疼痛の処置用の化合物
US20110020474A1 (en) 2009-07-27 2011-01-27 Novabay Pharmaceuticals, Inc. Methods of Treating Infections of the Nail or Skin Using Hypohalite
CN102573500A (zh) 2009-08-06 2012-07-11 纽拉尔图斯制药公司 巨噬细胞相关疾病的治疗
US8486155B2 (en) * 2010-05-13 2013-07-16 Ethicon Endo-Surgery, Inc. Fistula repair plug having multiple layers
EP2510944A1 (en) 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
CA3254125A1 (en) * 2011-10-08 2025-07-08 Next Science IP Holdings Pty Ltd Antimicrobial compositions and methods employing same
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav

Also Published As

Publication number Publication date
CN104619330A (zh) 2015-05-13
ES2657598T3 (es) 2018-03-06
US9999605B2 (en) 2018-06-19
EP3299022A1 (en) 2018-03-28
CN104619330B (zh) 2018-01-19
MX2015001019A (es) 2015-04-08
MX360207B (es) 2018-10-24
WO2014016157A1 (en) 2014-01-30
EP2877188B1 (en) 2017-10-25
CA2879362A1 (en) 2014-01-30
US20150174091A1 (en) 2015-06-25
SE1250891A1 (sv) 2014-01-25
SE536581C2 (sv) 2014-03-11
JP2015522632A (ja) 2015-08-06
CA2879362C (en) 2020-09-22
EP2877188A1 (en) 2015-06-03

Similar Documents

Publication Publication Date Title
JP6169693B2 (ja) 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤
KR102132543B1 (ko) 양이온성 살생물제를 포함하는 페트롤라툼-계 조성물
JP5002114B2 (ja) 亜塩素酸塩および過酸化水素を含有する相乗的抗菌性眼科用および皮膚科用製剤
CN105142728B (zh) 用于治疗表面创伤的组合物和方法
CN104307032B (zh) 一种止痛、抗菌、止血并促进伤口愈合的液体敷料
US20100284951A1 (en) Novel compositions for the treatment of wounds and skin care
AU2014343506C1 (en) Anti-inflammatory solution comprising sodium hypochlorite
Jacobsen Topical wound treatments and wound‐care products
JP2012521410A (ja) 薬用抗細菌クリームおよびその作製方法
MX2011009935A (es) Crema medicinal para dermatitis del pañal y un proceso para hacerla.
WO2020144564A1 (en) Composition for the treatment of skin lesions and irritations
US20110165276A1 (en) Composition for burn treatment
RU2188016C1 (ru) Клеевая лечебно-профилактическая композиция
WO2015159206A1 (en) Copper alloy microparticles for use in the treatment of an external skin lesion
RU2404745C2 (ru) Гидрофильная фармацевтическая композиция для лечения ожогов (варианты)
US12171796B2 (en) Hydrogel wound treatment
RU2546030C1 (ru) Средство "ихтиосин"
EP3968956B1 (en) A topical pharmaceutical mupirocin composition for bacterial infections and wound healing
CN119403561A (zh) 用于预防和治疗潮湿相关性皮肤损伤的组合物
HU221676B1 (hu) Gyógyászati készítmény, amely hatóanyagként jódot és ezüst-nitrátot tartalmazó etanolos, vagy vizes-etanolos oldatokból áll és eljárás az előállítására
Bradbury et al. Managing chronic wounds with Acticoat Moisture Control™

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20150310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160404

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160404

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170124

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170420

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170606

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170628

R150 Certificate of patent or registration of utility model

Ref document number: 6169693

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees